Many factors affect the pulmonary drug delivery and stability of the nanoparticles an acupuncture consisting of bronchial asthma. Present research envisages on the development of dry powder nanoparticles as insuf lation a acupuncture consisting of bronchial asthma (allergy due to Aspergillus fumigatus) using physical mixing and spray drying. Different founding are prepared and characterized with suitable excipients like lactose and trehalose. The particle size distribution of nano milled and spray-dried particles of Terbutaline Sulphate and Itraconazole showed unimodal size distribution. The formulations prepared with trehalose as the carrier showed less D v90 , D v50 and D v10 values due to the ineness in the particles of trehalose when compared to lactose. The D v50 and D v10 values were in the range of mountains of 0.43-0.89 µm and 0.21-0.49 µm for all formulations, which shows the primary particle size in the nanometer scale. Smooth and nearly spherical particles were produced for spray-dried formulations when compared to milled formulations. Zeta potential comes across until be between +17±0.13 to +32±0.12, which explains the particles as moderately stable. MMAD values ranges from 3.19 µm to 4.78 µm for milled nanoparticles and 3.45 µm to 4.21 µm for spraydried particles. Formulated nanoparticles exhibited good spreading properties, which will allow all the particles to deposition palmy profusion territories consisting of the lung. In-vitro drug release studies explains that spray-dried formulations of Terbutaline sulpahte and Itraconazole using lactose as excipients released the drug upto 98.9% and 99.1% in 180mts.
INTRODUCTION
Nanoparticles gained therapeutic importance lourishing respiratory organ trental delivery due to its ability to enter into deeper parts of the lung, to elude powerful pulmonic dendrites along with mucociliary consent methods, sequent in prolonged residence time (Daniher and Zhu, 2008; Daraghmeh et al., 2002) . Statistical data on asthma showed that children missed 12.8 million school days, with 444,000 patients hospitalized, 1.7 million emergency visits, physician visits of about 10.6 million and 3,613 deaths (NIH Publication 10-7542., 2010) . Due to the unique features like surface to mass ratio, the ability to absorb creates an exterior region to carry various compounds, and nanoparticles gained much importance in acupuncture in reference to an asthma attack. Dry powder inhaler (DPIs) inds up to be effective to deliver a drug into the lung ef iciently (Dolovich and Dhand, 2011; Edwards et al., 1998) . DPIs can be easily carried with less drug loss as well as provides spectacular drug effectively to the lung (Hickey and Garcia-Contreras, 2001; Roy and Vij, 2010) . The particles with a mass median aerodynamic diameter (MMAD) under 5µ hit in order to be the best candidates for a pulmonic orphan drug. Particles in the above range will deposit in stroke and therefore increases systemic drug absorption (Zhang et al., 2011; Li and Mansour, 2011) .
Aspergillus fumigatus is a fungus which is likely one of the major cause for asthma. Hence in this comprehensive study, Terbutaline Sulphate (a bronchodilator) and Itraconazole (an antifungal) was used for spectacular acupressure going from asthama attack. This study was planned to design, optimize and develop a novel dry powder aerosol using physical mixing and spray drying.
MATERIALS AND METHODS
Terbutaline Sulphate and Itraconazole were obtained from KP Labs Hyderabad. Lactose was obtained from Drugs India Hyderabad. Trehalose from Hyashibara Co Ltd Japan. Methanol was obtained from Himalaya Scienti ic Nellore. Other chemicals used in the entire work owe allegiance analytic shortlist.
Figure 1: IR Spectrum -Terbutaline Sulphate

Pre-formulation
Preformulation parameters like organoleptic properties, Solubility, the Melting point was determined. Compatibility between drug and excipients and thermal properties of the drug was determined using FT-IR Spectroscopy and Differential Scanning Milled Trehalose (7.5.0 g) ties, drugs and excipients were milled to nano size and further evaluations were done (Meenach et al., 2012; Ali and Lamprecht, 2014) . 125.5 123.9±0.08
Formulation
Physical Mixing
Figure 9: Water vapor natural process isotherms at 250C for raw API vs. milled API (weight change % vs. RH)
Terbutaline Sulphate, Itraconazole and the sugar used as carriers (Lactose, Trehalose) were taken in speci ied quantities shown in Table 2 and dried at 37 0 c using vacuum oven for 12 Hrs. The size of drug and carriers were reduced using grinding mill (Jet mill, air is supplied at 110 psig with air classi ier speed of 4200 rpm) for 3 Hrs for nanosized particles and for 2 hours for ine particles (Jet mill, air is supplied at 90 psig with air classi ier speed of 3800 rpm). Calculated amount of Terbutaline Sulphate and Itraconazole was mixed separately in every formulation with ine lactose and micronized 
Spray Drying
Mini spray dryer (SS Laboratory Spray Dryer (LSD 01)) using a high-performance cyclone separator was used for performing a spray drying process using dilute solutions. All the ingredients were taken in speci ied quantities shown in Table 3 .
Solution-1
Dilute way out used to be mapped out by means of dissolving each ingredient in calculated quantities, consisting of Terbutaline Sulphate with lactose and Terbutaline Sulphate with trehalose using methanol to make total powder concentrations of 0.4%W/v.
Solution-2
Dilute way out turned into mapped out with the aid of dissolving each ingredient in calculated quantities, consisting of Itraconazole with lactose and Itraconazole with Trehalose using methanol to make total powder concentrations of 0.4%W/v (Olsson et al., 2013) .
Solution-3
Dilute solution way out used to be mapped out by means of dissolving each ingredient in calculated quantities, consisting of Terbutaline Sulphate and Itraconazole with lactose, Terbutaline Sulphate and Itraconazole with Trehalose using methanol to make total powder concentrations of 0.8%W/v (Pritchard, 2001) . Sprayer dehydrated vectors have been separated by cyclone separator and sealed in the glass vials and stored in dessicator under ambient pressure. Outlet temperatures were given in Table 4 . Average ill weight per capsule 20 capsules were randomly taken and the overall table of contents was taken way externally, shedding a bit much a part of the over shell as completely as possible (Rogueda and Traini, 2007) . 20 capsules were weighed for content and determined using the following formulae.
Spray Drying-Conditions
Evaluation
Average ill weight (mg) = Content present in 20 capsules (mg)/20 ____(1)
Moisture content
In a 5 ml volumetric lask, 6-10 mg of sample was dissolved in methanol and hydranal KF reagent was illed in the reaction cell and test solutions were injected into it. The moisture content present in the sample was calculated by conducting all the experiments in triplicate (n = 3) (Meenach et al., 2013) . Moisture content of the sample was calculated using the formula SF*100/W ______ (2) Where W = Coef icient the Sample, in mg, S = Volume of the KF reagent, in ml, F = the water compare factor of KF reagent, in mg.
Percentage Yield
Percentage yield was determined by taking the weights of reactants (drug and excipients) and prod- 
Scanning electron microscopy (SEM)
Hitachi S-4300 microscope was used to analyze the shape and morphology. Double-sided mucilaginous atomic number 6 directories have always been compensate alum stubs and samples were gold coated using Emscope SC400 coating system. Working distance with 13-15mm was set and a beam of electrons with fast electricity of 5-10 kV was used. Similar conditions were maintained for all the magni i cations (Shekunov et al., 2007) .
Size distribution using laser light diffraction
Shimadzu laser light diffractor was used to analyze the size plus iller redistribution of the particles in all the formulations. The samples were ultrasonicated for 10 min by dissolving the samples in chloroform. The dispersion was transferred into a measuring radical cell plus stored stirring. Volumebased measurements like Dv1mw980, Dv50, and Dv90 were used for the characterization of particles . The span value was calculated using the formula below (Zhang et al., 2011; Mansour et al., 2013) .
((Dv90-Dv10)/Dv50) _______(4)
Particle Size and Zeta potential
Malvern zeta sizer was used to measure the electrophoretic mobility of the particles present in all the formulations by diluting the sample with water.
Determination of MMAD using cascade impactor
Seven ultimateness fall impactor was used to determine the MMAD. Randomly selected capsules (3 per each formulation) were needle pierced and was drawn into the cascade impactor with a controlled low rate of 28 L/min with delay time of 10s. A total of 25.5mg (TER-A to TER-D) total per run, 100mg (ITR-A to ITR-D) total per run and 125.5mg (TER: ITR-A to TER: ITR-D) total per run. After deposition of DPI, Terbutaline Sulphate and Itraconazole content was determined in each chamber by UV Spectroscopy. Absorbance was detected at 276nm for Terbutaline Sulphate and 264nm for Itraconazole. MMAD and GSD at each stage for all the samples were calculated using MMAD calculated.
In vitro drug release studies
The dissolution studies are ordered palmy phosphate buffer with pH 7.4 at 37 • C using a rotating basket apparatus at 50rpm. The studies were performed with milled and spray-dried particles containing Terbutaline Sulphate and Itraconazole. At a predetermined time interval, 5ml aliquots had been withdrawn and a fresh 5 ml buffer was added simultaneously. Cumulative release of Terbutaline Sulphate and Itraconazole by UV/Vis-spectroscopy (λmax: 276 nm for Terbutaline Sulphate, λmax: 264 nm for Itraconazole) (Li et al., 2014) . 
RESULTS AND DISCUSSION
Preformulation FTIR and DSC studies were performed for individual drugs and excipients. From the results, no incompatibility was observed between the drugs and excipients. The results were shown in Figures 1,  2 , 3, 4, 5, 6, 7 and 8. All the drugs, excipients and formulations were subjected to various physical properties like Bulk Density, Tapped Density, Angle of Repose, Hausner's Ratio and Carr's Index to evaluate the density and low of powder. Average ill weight also determined. All the formulations were found to have good low properties when compared to plain drug and excipients. Due to the good low property, all the formulations can be effectively delivered through the dry powder inhaler, which is very important in formulating as DPIs. Results were shown in Table 1 and Table 5 .
Moisture Content
Moisture content for raw drugs and formulations was done by Karl Fisher serial dilutions. The residual water content for raw Terbutaline Sulphate and raw Itraconazole was found that one may be 4.41±0.18 and 7.62±0.11, respectively. Moisture content of all the formulations prepared by physical mixing and spray drying was decreased when compared to the raw drugs, which may be due to the general ubiety of lactose and trehalose in all the formulations.
Moisture content of formulations prepared by physical mixing ranges from 3.80±0.44 to 4.89±0.22. Formulations (Physical mixing) containing the combination drugs showed a slight increase, which may be due to the powerful ubiquity of Itraconazole (Fluffy Powder). Formulations prepared by way of atomizer brushing showed less moisture content when compared to the formulations prepared by physical mixing and ranges from 3.12±0.18 to 4.21±0.27. Results record in Figure 9 & Figure 10 .
Percentage Yield and Drug Content
The spray-dried formulation showed less percentage yield (ranges from 77.50-88.75) when compared to milled formulations (ranges from 95.69-98.90). Less percentage yield for spray-dried formulations, when compared to milling, maybe due to the conditions used in the spray drying process. Drug content comes across in order to be within lim- Table 6 .
Scanning Electron Microscopy
The particle size of raw material was found to have a maximum particle size that may interrupt the respiratory passages. Hence the particle size has been decreased to the respirable-size using milling and spray drying. Particles were found that one may be smooth and spherical for spray-dried formulations. Formulations prepared through milling were found to have rough and irregular in shape. Results re lect in Figures 11, 12 and 13 .
Particle sizing and Size distribution
All formulations tried and true nonparametric littleness distributions. The formulations prepared with trehalose as the carrier showed less D v90 , D v50 and D v10 values due to the ineness in the particles of trehalose when compared to lactose. The D v50 values were in the variety of 0.43-0.89 µm for all formulations. The D v10 values were in the range of mountains of 0.21-0.49 µm. This shows that all the particles were found planned in very particulate matter range and results re lect in Table 7 and Figure 14 .
Zeta Potential
From the results, it was found that the formulations prepared by using milled trehalose as carrier attained less particle size when compared to milled lactose. Further, individual formulations attained less particle sizes when compared to the formulations in combination. Polydispersity index was found impending in a very range of mountains of 0.101 to 0.467, which explains the particle size distribution as monodisperse. Zeta potential was found so be between +17±0.13 to +32±0.12, which explains the particles as moderately stable. Results had been shown in Table 8 and Figure 15 &Figure 16.
Determination of MMAD (Mean Median Aerodynamic diameter)
Particle deposition on lower degrees containing ultimate twain totally that one may phase 7 (the lowest stage) is said. General, spectacular percent deposit towards phase a meg increased for unmilled formulations and formulations in which the drugs are given in combination. The exception to this, spraydried formulations showed very slight differences in % deposition at stage 1. This trend was opposite for stage 4, where the amount of powder deposited on this stage increased in spray-dried systems when compared to physically mixed systems. From the results, it was found that signi icant deposition was seen in lower stages (Stages 4-7), which explains that the particle may deposit in the deep lung region, thereby increasing the therapeutic bene it. Results were shown in Table 9 and Figure 17 .
Figure 14: Laser light diffraction particle sizing and size distribution
In-vitro drug release studies:
Dissolution studies indicate that formulations prepared using milled trehalose release the drug at a faster rate due to its very ine particle size. TER-A(sd) and ITR-A(sd) was found that one may be the best formulations which released the drug upto 98.9% and 99.1% in 180 mts. All the formulations prepared viva atomizer drying has high % depositions from stage 2 to 7 when compared to other formulations, which made the spray-dried formulations the most effective drug delivery throughout the lung. Results were shown in Figure 
CONCLUSIONS
Demanding tasks in formulating dry powder nanoparticles is achieving the respirable particle size that avoids the physical limitations of the general stroke and delivering the synergist to a powerful target site. From the results obtained, it was evident that the prepared formulations can be prepared as DPIs that releases the drug directly into the lung ef iciently for the acupressure going from asthma. Spray drying was found to be the best method suitable for the readying containing dry powder nanoparticles when compared to physical mixing of milled drug and excipients. Combination foams could provide coeval delivery to the synoptical computer epithetical legal action maximizing the capability outcome in reference to the medicinal drugs.
